| Old Articles: <Older 2611-2620 Newer> |
|---|
 |
Bio-IT World
Dec 2005/Jan 2006
Michael A. Greeley |
Infinite Demand for the Unavailable The bio-IT field is once again attracting venture capital, but at a more moderate, deliberate pace than the euphoria of the late 1990s.   |
Bio-IT World
Dec 2005/Jan 2006
Scott Lundstrom |
Buying Innovation in Web Services Delivering improved rates of innovation and change to the life science organization may be the largest value a company gets from Web services. |
Bio-IT World
Dec 2005/Jan 2006
Davies & Withrow |
Wal-Mart, Google, and the Future of Medicine Industry leaders at a recent conference were unanimous in their conviction that personalized medicine will change the practice of medicine and drug development but expressed grave concern at the lack of appropriate medical education currently available to bring that paradigm shift to fruition. |
Bio-IT World
Dec 2005/Jan 2006
Kevin Davies |
9/11 DNA Panel Report A panel set up to advise on DNA identification following the World Trade Center attack on September 11, 2001, has issued a report on its findings, citing the need for new software tools. |
Bio-IT World
Dec 2005/Jan 2006
Robert M. Frederickson |
Labcyte Demonstrates 'Sound' Transfer As mundane as the topic of fluid management may seem, it is big business. And this developer of microfluidic systems' new technology is well suited to high-throughput biological applications where large numbers of different fluids must be transferred rapidly and sequentially. |
Bio-IT World
Dec 2005/Jan 2006
John Russell |
GeneGo's Pathway to Profits Steady growth in literature citations plus several major pharmaceutical deals and now a recent FDA commitment suggest pathway technology is gaining sufficient credibility and the furthest along commercially of all the systems biology niches. |
BusinessWeek
January 16, 2006
Arlene Weintraub |
Crossing The Gene Barrier On the frontiers of biotech, two scientists are mingling the genetic materials of man and beast in new ways. The hoped-for outcome: Radical treatments for some of mankind's most intractable ailments. |
BusinessWeek
January 16, 2006
Jessi Hempel |
Aetna: Succession At Full Speed Can incoming Aetna CEO Ron Williams keep the health insurer on its hot streak? |
BusinessWeek
January 16, 2006
Arlene Weintraub |
What's Ethical And What Isn't? The debate over using human cells in animals for medical research. |
BusinessWeek
January 16, 2006
Arlene Weintraub |
Side of Valves, Hold the Bacon Someday, organs from pigs may save human lives. But solving the genetic engineering problems is turning out to be tricky. |
| <Older 2611-2620 Newer> Return to current articles. |
